These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
525 related articles for article (PubMed ID: 37191303)
1. Factors Associated With Marshallese and Hispanic Adults' Willingness to Receive a COVID-19 Booster Dose. Purvis RS; Vincenzo JL; Spear M; Moore R; Patton SK; Callaghan-Koru J; McElfish PA; Curran GM J Prim Care Community Health; 2023; 14():21501319231171440. PubMed ID: 37191303 [TBL] [Abstract][Full Text] [Related]
2. Reaching late adopters: factors influencing COVID-19 vaccination of Marshallese and Hispanic adults. Vincenzo JL; Spear MJ; Moore R; Purvis RS; Patton SK; Callaghan-Koru J; McElfish PA; Curran GM BMC Public Health; 2023 Apr; 23(1):631. PubMed ID: 37013523 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 booster uptake among US adults: Assessing the impact of vaccine attributes, incentives, and context in a choice-based experiment. Raman S; Kriner D; Ziebarth N; Simon K; Kreps S Soc Sci Med; 2022 Oct; 310():115277. PubMed ID: 36001917 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults - United States, November-December 2022. Lu PJ; Zhou T; Santibanez TA; Jain A; Black CL; Srivastav A; Hung MC; Kriss JL; Schorpp S; Yankey D; Sterrett N; Fast HE; Razzaghi H; Elam-Evans LD; Singleton JA MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(7):190-198. PubMed ID: 36795677 [TBL] [Abstract][Full Text] [Related]
5. Influences on COVID-19 booster uptake among adults intending to receive a booster: a qualitative study. Moore R; Purvis RS; Willis DE; Li J; Selig JP; Ross J; McElfish PA Health Promot Int; 2024 Jun; 39(3):. PubMed ID: 38902983 [TBL] [Abstract][Full Text] [Related]
6. Factors Associated With Racial/Ethnic Group-Based Medical Mistrust and Perspectives on COVID-19 Vaccine Trial Participation and Vaccine Uptake in the US. Thompson HS; Manning M; Mitchell J; Kim S; Harper FWK; Cresswell S; Johns K; Pal S; Dowe B; Tariq M; Sayed N; Saigh LM; Rutledge L; Lipscomb C; Lilly JY; Gustine H; Sanders A; Landry M; Marks B JAMA Netw Open; 2021 May; 4(5):e2111629. PubMed ID: 34042990 [TBL] [Abstract][Full Text] [Related]
7. County-level barriers in the COVID-19 vaccine coverage index and their associations with willingness to receive the COVID-19 vaccine across racial/ethnic groups in the U.S. Fernandez JR; Strassle PD; Richmond J; Mays VM; Forde AT Front Public Health; 2023; 11():1192748. PubMed ID: 37900019 [TBL] [Abstract][Full Text] [Related]
8. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial. Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843 [TBL] [Abstract][Full Text] [Related]
9. Willingness and Perceptions Regarding COVID-19 Vaccine Booster Dose in Pakistani Vaccinated Population: A Cross-Sectional Survey. Moeed A; Najeeb H; Saleem A; Asghar MS; Rafi HM; Khattak AK; Bilal Z; Seboka BT Front Public Health; 2022; 10():911518. PubMed ID: 35844859 [TBL] [Abstract][Full Text] [Related]
10. Time to COVID-19 Vaccination by Language and Country of Origin. Nolan MB; Chrenka E; DeSilva MB JAMA Netw Open; 2024 Oct; 7(10):e2437388. PubMed ID: 39361282 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study. Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090 [TBL] [Abstract][Full Text] [Related]
12. Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance. Fleming-Dutra KE; Britton A; Shang N; Derado G; Link-Gelles R; Accorsi EK; Smith ZR; Miller J; Verani JR; Schrag SJ JAMA; 2022 Jun; 327(22):2210-2219. PubMed ID: 35560036 [TBL] [Abstract][Full Text] [Related]
13. Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study. Luk TT; Lui JHT; Wang MP J Med Internet Res; 2022 Oct; 24(10):e39063. PubMed ID: 36179132 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study. Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506 [TBL] [Abstract][Full Text] [Related]
15. Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study. Qin C; Yan W; Du M; Liu Q; Tao L; Liu M; Liu J Front Public Health; 2022; 10():986916. PubMed ID: 36589991 [TBL] [Abstract][Full Text] [Related]
16. Educational Intervention to Increase COVID-19 Vaccine Uptake in Rural Patients with Chronic Diseases: Lessons Learned from An Innovative Academic-Community Partnership. Misra R; Kirk B; Shawley-Brzoska S; Totzkay D; Morton C; Kuhn S; Harris M; McMillion M; Darling E Int J Environ Res Public Health; 2024 Jan; 21(1):. PubMed ID: 38248535 [TBL] [Abstract][Full Text] [Related]
18. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022. Taylor CA; Whitaker M; Anglin O; Milucky J; Patel K; Pham H; Chai SJ; Alden NB; Yousey-Hindes K; Anderson EJ; Teno K; Reeg L; Como-Sabetti K; Bleecker M; Barney G; Bennett NM; Billing LM; Sutton M; Talbot HK; McCaffrey K; Havers FP; MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):466-473. PubMed ID: 35324880 [TBL] [Abstract][Full Text] [Related]
19. Overcoming barriers and enhancing facilitators to COVID-19 vaccination in the Hispanic community. Moore R; Rojo MO; Purvis RS; Marin LP; Yáñez J; Reece S; Wells C; Vaughn B; McElfish PA BMC Public Health; 2022 Dec; 22(1):2393. PubMed ID: 36539771 [TBL] [Abstract][Full Text] [Related]
20. Willingness to accept a second COVID-19 vaccination booster dose among healthcare workers in Italy. Della Polla G; Miraglia Del Giudice G; Folcarelli L; Napoli A; Angelillo IF; Front Public Health; 2022; 10():1051035. PubMed ID: 36568799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]